Oncology Letters · 2015 · 10 citations · 14 references
MedicineMolecular BiologyOncologyApoptosisMetastasisMolecular OncologyCancer Cell SignalingSignal Transduction In CancerApoptosis Signaling In CancerApoptosis TargetingApoptotic Signaling In CancerBcl-2 Protein ExpressionCancer Signaling PathwaysShort Hairpin Rna
The present study aimed to investigate the effects of Na+/H+ exchanger regulatory factor 1 (NHERF1) gene knockdown, using short‑hairpin RNA (shRNA), on the malignant behaviors of prostate cancer cells. A pSuper.puro NHERF1 shRNA vector was transfected into PC‑3M prostate cancer cells using Lipofectamine 2000. Stable cell lines were obtained and NHERF1 knockdown was verified through western blot analysis. MTT assays were then used to measure PC‑3M cell proliferation; in addition, cell migration was assessed using a wound healing assay. Flow cytometry was employed in order to determine the effects of NHERF1 knockdown on apoptosis. Expression levels of apoptotic pathway proteins B cell lymphoma‑2 (Bcl‑2) and Bcl‑2‑associated X protein were then determined by western blot analysis. The results demonstrated that shRNA knockdown of NHERF1 significantly suppressed the proliferation of PC‑3M cells by >50%. In addition, knockdown of NHERF1 significantly inhibited the migration of PC‑3M cells. PC‑3M cells harboring NHERF1 shRNA exhibited significantly increased apoptosis, with an ~4‑fold increase compared with that of the parental PC‑3M cells and cells transfected with an empty vector. Furthermore, the results revealed that knockdown of NHERF1 reduced the protein expression of Bcl‑2, although the expression of Bax was unaltered. In conclusion, NHERF1 knockdown using shRNA inhibited the proliferation and migration of PC‑3M cells and promoted apoptosis, highlighting the role of NHERF1 in prostate cancer progression.
14
Contact-dependent inhibition of EGFR signaling by Nf2/Merlin
Marcello Curto, Banumathi K. Cole, Dominique Lallemand et al. · The Journal of Cell Biology · 2007 · 364 citations · Full text
Phenotypic heterogeneity of end-stage prostate carcinoma metastatic to bone
Martine P. Roudier, Lawrence D. True, Celestia S. Higano et al. · Human Pathology · 2003 · 308 citations
Medicine, Cancer Biology, Oncology +14
PTEN, NHERF1 and PHLPP form a tumor suppressor network that is disabled in glioblastoma
Jennifer R. Molina, Nitin Agarwal, Fabiana C. Morales et al. · Oncogene · 2011 · 163 citations